Julius Clinical published an article examining how earlier use of real-world data supports more precise, practical, and executable development strategies for Parkinson's trials.
Published
Signal category
Research & Knowledge
Quote
“Our latest article, featuring insights from Michael Markowitz, MD, MSPH, MBA, Expert Medical Scientist at P95 Julius Clinical, examines how earlier use of real-world data can support more precise, practical, and executable development strategies.”
— Julius Clinical team
Company
- Industry
- Pharmaceutical Manufacturing
- Location
- Zeist, NL
- Company size
- 232 employees
P95 Julius Clinical is a global, science-led contract research organization (CRO) supporting clinical development from early-phase trials through late-phase and real-world evidence programs. The company specializes in complex research for biotech and pharmaceutical sponsors, with deep expertise across neuroscience, infectious diseases and vaccines, and cardiovascular, renal, and metabolic diseases. Backed by a leadership of scientific luminaries and more than 500 experts spanning five continents, P95 Julius Clinical combines the reach of a larger CRO with the agility of a mid-sized partner.